Dopamine-glutamate interactions: A neural convergence mechanism of common schizophrenia risk variants

Biological Psychiatry

Volumn 69, Issue 10, 2011, Pages 912-913

  Tost, Heike ^a   Meyer Lindenberg, Andreas ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DEXTRO AMINO ACID OXIDASE ACTIVATOR; DOPAMINE; GLUTAMIC ACID; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

GENE INTERACTION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; NERVE CELL; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; SCHIZOPHRENIA;

DOPAMINE; GLUTAMIC ACID; HUMANS; RISK FACTORS; SCHIZOPHRENIA;

EID: 79955381532     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.03.013     Document Type: Note

References (13)

1. J.M. Van Rossum The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs Arch Int Pharmacodyn Ther 160 1966 492 494
2. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, and J.D. Bremner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214 (Pubitemid 24081509)
3. J.K. Seamans, N. Gorelova, D. Durstewitz, and C.R. Yang Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons J Neurosci 21 2001 3628 3638 (Pubitemid 32422827)
4. J.M. Stone, O.D. Howes, A. Egerton, J. Kambeitz, P. Allen, and D.J. Lythgoe Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis Biol Psychiatry 68 2010 599 602
5. P. Seeman, and H.C. Guan Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2(High) receptor Synapse 63 2009 935 939
6. A. Meyer-Lindenberg From maps to mechanisms through neuroimaging of schizophrenia Nature 468 2010 194 202
7. D.C. Nixon, M.J. Prust, F. Sambataro, H.Y. Tan, V.S. Mattay, R.B. Weinberger, and J.H. Callicott Interactive effects of DAOA (G72) and catechol-O-methyltransferase on neurophysiology in prefrontal cortex Biol Psychiatry 69 2011 1006 1008
8. K.K. Nicodemus, B.S. Kolachana, R. Vakkalanka, R.E. Straub, I. Giegling, and M.F. Egan Evidence for statistical epistasis between catechol-O- methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia Hum Genet 120 2007 889 906 (Pubitemid 46128844)
9. 108/158 Met genotype on frontal lobe function and risk for schizophrenia Proc Natl Acad Sci U S A 98 2001 6917 6922 (Pubitemid 32538317)
10. T.E. Goldberg, R.E. Straub, J.H. Callicott, A. Hariri, V.S. Mattay, and L. Bigelow The G72/G30 gene complex and cognitive abnormalities in schizophrenia Neuropsychopharmacology 31 2006 2022 2032
11. I. Chumakov, M. Blumenfeld, O. Guerassimenko, L. Cavarec, M. Palicio, and H. Abderrahim Genetic and physiological data implicating the new human gene G72 and the gene for [scap]d[r]-amino acid oxidase in schizophrenia Proc Natl Acad Sci U S A 99 2002 13675 13680 (Pubitemid 35215440)
12. J.H. Callicott, M.F. Egan, V.S. Mattay, A. Bertolino, A.D. Bone, B. Verchinksi, and D.R. Weinberger Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia Am J Psychiatry 160 2003 709 719 (Pubitemid 41079604)
13. H.Y. Tan, Q. Chen, S. Sust, J.W. Buckholtz, J.D. Meyers, and M.F. Egan Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function Proc Natl Acad Sci U S A 104 2007 12536 12541 (Pubitemid 47206173)